FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition for treating demodectic blepharitis and blepharoconjunctivitis, containing recombinant interferon specified in a group: recombinant interferon alpha, recombinant interferon beta, recombinant interferon gamma, boric acid, fluconazole and/or voriconazole with the ingredients of the composition taken in certain ratio, g in 1 ml.
EFFECT: higher therapeutic effect.
2 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
PHARMACEUTICAL COMPOSITION FOR TREATING DEMODECOSIS, POSSESSING ANTIPARASITIC, ANTIBACTERIAL, ANTIVIRAL, IMMUNOMODULATORY ACTION | 2013 |
|
RU2538710C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561048C1 |
PHARMACEUTICAL COMPOSITION IN FORM OF EYE DROPS FOR PREVENTING AND TREATING ALLERGIC EYE DISEASES | 2013 |
|
RU2549472C1 |
OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
EYE DROPS, WHICH HAVE ANTI-INFECTIOUS, ANTI-INFLAMMATORY AND ANTI-ALLERGIC ACTION | 2012 |
|
RU2493823C1 |
EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
Authors
Dates
2014-11-20—Published
2013-12-25—Filed